Chromocell Therapeutics C... (CHRO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.68
-0.02 (-0.74%)
At close: Jan 23, 2025, 3:59 PM
2.86
6.70%
After-hours Jan 23, 2025, 07:38 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -3.75 | -11.26 | -46.5 | -41.91 |
PS Ratio | n/a | n/a | n/a | 138.47 |
PB Ratio | -4.3 | -7.47 | -7.52 | -7.74 |
P/FCF Ratio | -28.22 | -17.67 | -17.38 | -7.64 |
P/OCF Ratio | -28.22 | -17.67 | -17.38 | -7.64 |
OCF/S Ratio | n/a | n/a | n/a | -18.13 |
Debt / Equity Ratio | -0.2 | -0.15 | -0.3 | -0.07 |
Quick Ratio | 0.01 | 0.01 | n/a | 0.02 |
Current Ratio | 0.01 | 0.01 | n/a | 0.02 |
Asset Turnover | n/a | n/a | n/a | 2.78 |
Interest Coverage | -13.23 | -16.51 | -3.32K | -807.8 |
Return on Equity (ROE) | 1.15 | 0.66 | 0.16 | 0.18 |
Return on Assets (ROA) | -76.57 | -44.64 | n/a | -9.19 |
Return on Capital (ROIC) | 1.06 | 0.63 | 0.33 | 0.38 |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 30.68% |
Net Profit Margin | n/a | n/a | n/a | -330.4% |
Pretax Profit Margin | n/a | n/a | n/a | -330.4% |
Operating Profit Margin | n/a | n/a | n/a | -677.16% |
FCF Margin | n/a | n/a | n/a | -1.81K% |
EBITDA Margin | n/a | n/a | n/a | n/a |